Invesco’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.6M Sell
836,510
-11,451
-1% -$274K ﹤0.01% 1485
2025
Q4
$22.6M Buy
847,961
+107,386
+15% +$2.57M ﹤0.01% 1403
2025
Q3
$15.8M Sell
740,575
-117,405
-14% -$2.78M ﹤0.01% 1567
2025
Q2
$18.5M Buy
857,980
+126,404
+17% +$2.35M ﹤0.01% 1478
2025
Q1
$12.2M Buy
731,576
+219,256
+43% +$3.98M ﹤0.01% 1697
2024
Q4
$9.4M Sell
512,320
-45,744
-8% -$738K ﹤0.01% 1902
2024
Q3
$8.58M Buy
558,064
+472,640
+553% +$7.88M ﹤0.01% 1926
2024
Q2
$1.39M Sell
85,424
-264,963
-76% -$4.28M ﹤0.01% 2776
2024
Q1
$6.48M Sell
350,387
-72,582
-17% -$1.8M ﹤0.01% 2067
2023
Q4
$13.2M Buy
422,969
+89,997
+27% +$2.15M ﹤0.01% 1640
2023
Q3
$6.94M Sell
332,972
-64,548
-16% -$1.75M ﹤0.01% 2007
2023
Q2
$9.52M Sell
397,520
-76,450
-16% -$1.7M ﹤0.01% 1847
2023
Q1
$8.92M Sell
473,970
-61,774
-12% -$1.18M ﹤0.01% 1886
2022
Q4
$8.53M Buy
535,744
+54,824
+11% +$857K ﹤0.01% 1955
2022
Q3
$7.87M Buy
480,920
+31,226
+7% +$506K ﹤0.01% 1950
2022
Q2
$6.34M Sell
449,694
-26,172
-5% -$488K ﹤0.01% 2153
2022
Q1
$11.5M Buy
475,866
+409,120
+613% +$9.9M ﹤0.01% 1884
2021
Q4
$1.56M Sell
66,746
-4,796
-7% -$96.5K ﹤0.01% 2895
2021
Q3
$1.19M Buy
71,542
+8,626
+14% +$166K ﹤0.01% 3031
2021
Q2
$1.53M Sell
62,916
-4,525
-7% -$102K ﹤0.01% 2947
2021
Q1
$1.74M Sell
67,441
-1,125,174
-94% -$49.5M ﹤0.01% 2837
2020
Q4
$63.8M Buy
1,192,615
+891,392
+296% +$44.3M 0.02% 942
2020
Q3
$12.4M Sell
301,223
-3,871
-1% -$167K ﹤0.01% 1549
2020
Q2
$14.8M Sell
305,094
-268,532
-47% -$12.9M 0.01% 1418
2020
Q1
$24.2M Sell
573,626
-950,634
-62% -$39.2M 0.01% 1120
2019
Q4
$65.2M Sell
1,524,260
-2,587,265
-63% -$113M 0.02% 875
2019
Q3
$148M Buy
4,111,525
+96,043
+2% +$2.91M 0.04% 519
2019
Q2
$107M Buy
4,015,482
+3,633,171
+950% +$92.8M 0.03% 652
2019
Q1
$10.3M Sell
382,311
-129,476
-25% -$3.02M ﹤0.01% 1553
2018
Q4
$8.28M Sell
511,787
-3,377
-0.7% -$65.6K ﹤0.01% 1633
2018
Q3
$10.7M Buy
515,164
+219,261
+74% +$3.45M ﹤0.01% 1656
2018
Q2
$4.52M Sell
295,903
-6,335
-2% -$113K ﹤0.01% 2202
2018
Q1
$6.79M Sell
302,238
-1,467,176
-83% -$40.6M ﹤0.01% 1772
2017
Q4
$53.3M Sell
1,769,414
-224,853
-11% -$7.19M 0.02% 745
2017
Q3
$75.1M Buy
1,994,267
+608
+0% +$19.8K 0.03% 603
2017
Q2
$55.6M Buy
1,993,659
+346,706
+21% +$10.3M 0.02% 727
2017
Q1
$56.6M Buy
1,646,953
+479,003
+41% +$16.9M 0.02% 729
2016
Q4
$33.7M Buy
1,167,950
+4,080
+0.4% +$108K 0.01% 967
2016
Q3
$37M Buy
1,163,870
+10,603
+0.9% +$359K 0.01% 911
2016
Q2
$37.4M Buy
1,153,267
+2,824
+0.2% +$94.5K 0.01% 890
2016
Q1
$32.2M Sell
1,150,443
-116,152
-9% -$2.53M 0.01% 940
2015
Q4
$45.2M Buy
1,266,595
+22,070
+2% +$778K 0.02% 804
2015
Q3
$41.2M Sell
1,244,525
-88,411
-7% -$3.68M 0.02% 831
2015
Q2
$55.8M Buy
1,332,936
+861,555
+183% +$33.3M 0.02% 757
2015
Q1
$15.4M Buy
471,381
+13,851
+3% +$476K 0.01% 1337
2014
Q4
$14.5M Hold
457,530
0.01% 1346
2014
Q3
$11.3M Hold
457,530
﹤0.01% 1480
2014
Q2
$10.3M Sell
457,530
-717,536
-61% -$15M ﹤0.01% 1540
2014
Q1
$28.6M Buy
1,175,066
+734,723
+167% +$18.6M 0.01% 1051
2013
Q4
$11M Sell
440,343
-463,802
-51% -$10.9M ﹤0.01% 1483
2013
Q3
$24.8M Buy
904,145
+343,333
+61% +$7.18M 0.01% 1065
2013
Q2
$10.2M Buy
+560,812
New +$7.72M ﹤0.01% 1409

Other funds holding ACAD